A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)

NCT03305809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Lewy Body Dementia

Interventions

DRUG: LY3154207
DRUG: Placebo

Sponsor

Eli Lilly and Company